CGVHD
Clinical trials for CGVHD explained in plain language.
Never miss a new study
Get alerted when new CGVHD trials appear
Sign up with your email to follow new studies for CGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop dangerous transplant side effect
Disease control Recruiting nowThis study is testing whether adding an experimental drug called BPC2001 to standard care can better prevent a serious complication called graft-versus-host disease (GvHD) after a stem cell transplant. The trial will enroll 50 adults with blood cancers who are receiving a transpl…
Matched conditions: CGVHD
Phase: PHASE2 • Sponsor: BioPhoenix Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Experimental cell therapy aims to tame dangerous transplant complication
Disease control Recruiting nowThis early-stage study is testing whether a special type of donor immune cell, called a Treg cell, given along with a protein called interleukin-2, can help control chronic graft-versus-host disease (cGVHD) in patients who haven't responded well to standard steroid treatments. Th…
Matched conditions: CGVHD
Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cell therapy tested for patients with severe transplant complications
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of an experimental cell injection called GT729 for people with chronic graft-versus-host disease (cGVHD) that hasn't improved with standard treatments. The trial will enroll 36 adults who developed cGVHD after…
Matched conditions: CGVHD
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Major study launches to track stem cell transplant complications
Knowledge-focused Recruiting nowThis study aims to collect information from 1,500 adults who recently received a stem cell transplant from a donor. Researchers want to better understand who develops chronic Graft-Versus-Host Disease (cGVHD), a serious complication where the donor cells attack the patient's body…
Matched conditions: CGVHD
Sponsor: Incyte Corporation • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC